CompletedNot Applicable

Kefir Peptides for Bone Fracture Healing

Taiwan30 participantsStarted 2020-04-13

Plain-language summary

This study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will be randomly assigned to receive either kefir peptide supplementation or standard treatment. The main purpose of this study is to determine whether kefir peptides can accelerate bone healing and improve recovery compared to standard care.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Bone mineral density T-score ≤ -2.5 measured by dual-energy X-ray absorptiometry (DXA)
✓. Acute fragility fracture of the distal radius or proximal humerus, and
✓. Postmenopausal women
✓. Age ≥ 50 years

Exclusion criteria

✕. Body mass index (BMI) \> 30 kg/m²
✕. Use of medications affecting bone metabolism for more than 4 months, including: glucocorticoids、thyroxine、antiepileptic drugs、bisphosphonates
✕. History of metabolic or systemic diseases affecting bone metabolism, including: hyperparathyroidism、hyperthyroidism、diabetes mellitus、 hepatic cirrhosis、renal insufficiency

What they're measuring

Radiographic Healing Score at 3 Months

Timeframe: 3 months after fracture fixation

Trial details

NCT IDNCT07166458

SponsorJen-Chieh Lai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-20

View on ClinicalTrials.gov More Bone Fractures trials